Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
Jeremy B Wingard, Francis S MahUPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAAbstract: Bepotastine besilate 1.5% solution is an H1-antihistamine recently approved by the Food and Drug Administration for the topical treatment of ocular i...
Enregistré dans:
Auteurs principaux: | Jeremy B Wingard, Francis S Mah |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/19e368d1c9334adc98c1108334b34dd1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%
par: Bergmann MT, et autres
Publié: (2014) -
Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials
par: Ciolino JB, et autres
Publié: (2015) -
Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops
par: Eiichi Uchio
Publié: (2008) -
Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
par: Cervantes LJ, et autres
Publié: (2011) -
Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis
par: Patricia B Williams, et autres
Publié: (2010)